Research programme: capsaicin prodrugs - Concentric Analgesics
Alternative Names: CA 011; CA-016; CA-01X; CA-05XLatest Information Update: 28 Nov 2021
At a glance
- Originator Concentric Analgesics
- Class Antipruritics; Catechols; Local anaesthetics; Monounsaturated fatty acids; Non-opioid analgesics; Polyunsaturated alkamides; Small molecules
- Mechanism of Action Substance P inhibitors; TRPV1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acute pain; Pain
Most Recent Events
- 28 Nov 2021 No recent reports of development identified for preclinical development in Acute pain in USA (Parenteral, Injection)
- 28 Nov 2021 No recent reports of development identified for preclinical development in Pain in USA (Parenteral, Injection)
- 23 Oct 2017 Concentric Analgesics plans a phase I trial for Chronic pain due to osteoarthritis in September 2018 (Concentric Analgesics pipeline, October 2017)